180 Life Sciences Corp.
(NASDAQ : ATNF)

( )
ATNF After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. -1.31%43.000.9%$1131.01m
ABBVAbbVie, Inc. -0.30%107.401.9%$1036.13m
JNJJohnson & Johnson -0.16%162.910.7%$988.77m
MRKMerck & Co., Inc. -0.11%73.280.7%$937.00m
LLYEli Lilly & Co. -2.07%221.721.1%$592.16m
BMYBristol-Myers Squibb Co. 0.02%59.851.0%$591.86m
AZNAstraZeneca Plc -1.86%57.631.0%$345.66m
NVSNovartis AG -0.34%82.310.2%$159.64m
CRVSCorvus Pharmaceuticals, Inc. -10.17%6.890.7%$147.73m
GSKGlaxoSmithKline Plc -1.14%38.060.2%$133.73m
RGENRepligen Corp. -7.09%285.576.8%$119.88m
RPRXRoyalty Pharma Plc -1.43%36.620.1%$118.91m
SNYSanofi -0.46%47.900.2%$117.35m
VTRSViatris, Inc. -0.87%13.700.0%$115.06m
APLSApellis Pharmaceuticals, Inc. 0.20%35.130.0%$104.57m

Company Profile

180 Life Sciences Corp. develops pharmaceuticals for chronic pain and inflammatory diseases. It operates as a clinical-stage biotechnology company focused on the development of novel drugs that fulfil unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded on September 7, 2016 and is headquartered in Palo Alto, CA.